Corynebacterium jeikeium: Difference between revisions
From IDWiki
Corynebacterium jeikeium
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
* Species of [[Corynebacterium|''Corynebacterium'']] that causes opportunistic infections, most closely associated with hematologic stem cell transplant patients |
* Species of [[Corynebacterium|''Corynebacterium'']] that causes opportunistic infections, most closely associated with hematologic stem cell transplant patients |
||
* Clinical presentations include bacteremia, prosthetic valve endocarditis, meningitis, and peritonitis |
* Clinical presentations include bacteremia, prosthetic valve endocarditis, meningitis, and peritonitis |
||
+ | * Essentially universally susceptible to [[vancomycin]] and [[linezolid]] |
||
− | |||
+ | * High rates of resistance to beta lactams; may be fluoroquinolone or tetracycline susceptible<ref name=":0">Neemuchwala A, Soares D, Ravirajan V, Marchand-Austin A, Kus JV, Patel SN. ''In Vitro'' Antibiotic Susceptibility Pattern of Non-diphtheriae Corynebacterium Isolates in Ontario, Canada, from 2011 to 2016. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e01776-17. doi: [https://doi.org/10.1128/aac.01776-17 10.1128/AAC.01776-17]. PMID: [https://pubmed.ncbi.nlm.nih.gov/29339389/ 29339389]; PMCID: [http://www.ncbi.nlm.nih.gov/pmc/articles/pmc5914010/ PMC5914010].</ref> |
||
+ | {| class="wikitable sortable" |
||
+ | |+From <ref name=":0" /> |
||
+ | !Antibiotic |
||
+ | !Isolates |
||
+ | !% Susceptible |
||
+ | |- |
||
+ | |[[Penicillin]] |
||
+ | |76 |
||
+ | |0 |
||
+ | |- |
||
+ | |[[Ampicillin]] |
||
+ | |76 |
||
+ | |ND |
||
+ | |- |
||
+ | |[[Oxacillin]] |
||
+ | |76 |
||
+ | |ND |
||
+ | |- |
||
+ | |[[Erythromycin]] |
||
+ | |76 |
||
+ | |11.8 |
||
+ | |- |
||
+ | |[[Clindamycin]] |
||
+ | |76 |
||
+ | |2.6 |
||
+ | |- |
||
+ | |[[Ciprofloxacin]] |
||
+ | |75 |
||
+ | |35.5 |
||
+ | |- |
||
+ | |[[Levofloxacin]] |
||
+ | |75 |
||
+ | |ND |
||
+ | |- |
||
+ | |[[Moxifloxacin]] |
||
+ | |76 |
||
+ | |35.5 |
||
+ | |- |
||
+ | |'''[[Tetracycline]]''' |
||
+ | |'''76''' |
||
+ | |'''92.1''' |
||
+ | |- |
||
+ | |'''[[Vancomycin]]''' |
||
+ | |'''76''' |
||
+ | |'''100''' |
||
+ | |- |
||
+ | |[[Trimethoprim-sulfamethoxazole]] |
||
+ | |76 |
||
+ | |18.4 |
||
+ | |- |
||
+ | |[[Tigecycline]] |
||
+ | |76 |
||
+ | |ND |
||
+ | |- |
||
+ | |'''[[Rifampin]]''' |
||
+ | |'''76''' |
||
+ | |'''97.4''' |
||
+ | |- |
||
+ | |'''[[Quinupristin-dalfopristin]]''' |
||
+ | |'''76''' |
||
+ | |'''89.5''' |
||
+ | |- |
||
+ | |'''[[Linezolid]]''' |
||
+ | |'''76''' |
||
+ | |'''100''' |
||
+ | |- |
||
+ | |'''[[Gentamicin]]''' |
||
+ | |'''76''' |
||
+ | |'''81.6''' |
||
+ | |- |
||
+ | |'''[[Daptomycin]]''' |
||
+ | |'''75''' |
||
+ | |'''89.5''' |
||
+ | |- |
||
+ | |[[Chloramphenicol]] |
||
+ | |75 |
||
+ | |ND |
||
+ | |- |
||
+ | |[[Nitrofurantoin]] |
||
+ | |76 |
||
+ | |ND |
||
+ | |} |
||
+ | {| class="wikitable" |
||
+ | | |
||
+ | | |
||
+ | | |
||
+ | | |
||
+ | | |
||
+ | | |
||
+ | |- |
||
+ | |Penicillin |
||
+ | |76 |
||
+ | |0.5 to >8 |
||
+ | |>8 |
||
+ | |>8 |
||
+ | |0 |
||
+ | |- |
||
+ | | Ampicillin |
||
+ | |76 |
||
+ | |≤0.12 to >8 |
||
+ | |>8 |
||
+ | |>8 |
||
+ | |ND |
||
+ | |- |
||
+ | | Oxacillin |
||
+ | |76 |
||
+ | |0.5 to >4 |
||
+ | |>4 |
||
+ | |>4 |
||
+ | |ND |
||
+ | |- |
||
+ | | Erythromycin |
||
+ | |76 |
||
+ | |≤0.25 to >4 |
||
+ | |>4 |
||
+ | |>4 |
||
+ | |11.8 |
||
+ | |- |
||
+ | | Clindamycin |
||
+ | |76 |
||
+ | |≤0.5 to >2 |
||
+ | |>2 |
||
+ | |>2 |
||
+ | |2.6 |
||
+ | |- |
||
+ | | Ciprofloxacin |
||
+ | |75 |
||
+ | |≤1 to >2 |
||
+ | |>2 |
||
+ | |>2 |
||
+ | |35.5 |
||
+ | |- |
||
+ | | Levofloxacin |
||
+ | |75 |
||
+ | |≤0.25 to >4 |
||
+ | |>4 |
||
+ | |>4 |
||
+ | |ND |
||
+ | |- |
||
+ | | Moxifloxacin<sup>''b''</sup> |
||
+ | |76 |
||
+ | |≤0.25 to >4 |
||
+ | |4 |
||
+ | |>4 |
||
+ | |35.5 |
||
+ | |- |
||
+ | | Tetracycline |
||
+ | |76 |
||
+ | |≤2 to >16 |
||
+ | |≤2 |
||
+ | |≤2 |
||
+ | |92.1 |
||
+ | |- |
||
+ | | Vancomycin |
||
+ | |76 |
||
+ | |≤0.25 to 2 |
||
+ | |0.50 |
||
+ | |1 |
||
+ | |100 |
||
+ | |- |
||
+ | | Trimethoprim-sulfamethoxazole |
||
+ | |76 |
||
+ | |≤0.5 to >4 |
||
+ | |>4 |
||
+ | |>4 |
||
+ | |18.4 |
||
+ | |- |
||
+ | | Tigecycline |
||
+ | |76 |
||
+ | |≤0.03 to >0.5 |
||
+ | |0.12 |
||
+ | |0.25 |
||
+ | |ND |
||
+ | |- |
||
+ | | Rifampin |
||
+ | |76 |
||
+ | |≤0.5 to >4 |
||
+ | |≤0.5 |
||
+ | |≤0.5 |
||
+ | |97.4 |
||
+ | |- |
||
+ | | Quinupristin-dalfopristin |
||
+ | |76 |
||
+ | |≤0.5 to 4 |
||
+ | |≤0.5 |
||
+ | |2 |
||
+ | |89.5 |
||
+ | |- |
||
+ | | Linezolid |
||
+ | |76 |
||
+ | |≤1 |
||
+ | |≤1 |
||
+ | |≤1 |
||
+ | |100 |
||
+ | |- |
||
+ | | Gentamicin |
||
+ | |76 |
||
+ | |≤2 to >16 |
||
+ | |≤2 |
||
+ | |>16 |
||
+ | |81.6 |
||
+ | |- |
||
+ | | Daptomycin |
||
+ | |75 |
||
+ | |≤0.5 to >4 |
||
+ | |≤0.5 |
||
+ | |1 |
||
+ | |89.5 |
||
+ | |- |
||
+ | | Chloramphenicol |
||
+ | |75 |
||
+ | |≤2 to >16 |
||
+ | |4 |
||
+ | |16 |
||
+ | |ND |
||
+ | |- |
||
+ | | Nitrofurantoin |
||
+ | |76 |
||
+ | |≤32 to >64 |
||
+ | |>64 |
||
+ | |>64 |
||
+ | |ND |
||
+ | |} |
||
{{DISPLAYTITLE:''Corynebacterium jeikeium''}} |
{{DISPLAYTITLE:''Corynebacterium jeikeium''}} |
||
[[Category:Gram-positive bacilli]] |
[[Category:Gram-positive bacilli]] |
Revision as of 10:37, 27 September 2023
- Species of Corynebacterium that causes opportunistic infections, most closely associated with hematologic stem cell transplant patients
- Clinical presentations include bacteremia, prosthetic valve endocarditis, meningitis, and peritonitis
- Essentially universally susceptible to vancomycin and linezolid
- High rates of resistance to beta lactams; may be fluoroquinolone or tetracycline susceptible[1]
Antibiotic | Isolates | % Susceptible |
---|---|---|
Penicillin | 76 | 0 |
Ampicillin | 76 | ND |
Oxacillin | 76 | ND |
Erythromycin | 76 | 11.8 |
Clindamycin | 76 | 2.6 |
Ciprofloxacin | 75 | 35.5 |
Levofloxacin | 75 | ND |
Moxifloxacin | 76 | 35.5 |
Tetracycline | 76 | 92.1 |
Vancomycin | 76 | 100 |
Trimethoprim-sulfamethoxazole | 76 | 18.4 |
Tigecycline | 76 | ND |
Rifampin | 76 | 97.4 |
Quinupristin-dalfopristin | 76 | 89.5 |
Linezolid | 76 | 100 |
Gentamicin | 76 | 81.6 |
Daptomycin | 75 | 89.5 |
Chloramphenicol | 75 | ND |
Nitrofurantoin | 76 | ND |
Penicillin | 76 | 0.5 to >8 | >8 | >8 | 0 |
Ampicillin | 76 | ≤0.12 to >8 | >8 | >8 | ND |
Oxacillin | 76 | 0.5 to >4 | >4 | >4 | ND |
Erythromycin | 76 | ≤0.25 to >4 | >4 | >4 | 11.8 |
Clindamycin | 76 | ≤0.5 to >2 | >2 | >2 | 2.6 |
Ciprofloxacin | 75 | ≤1 to >2 | >2 | >2 | 35.5 |
Levofloxacin | 75 | ≤0.25 to >4 | >4 | >4 | ND |
Moxifloxacinb | 76 | ≤0.25 to >4 | 4 | >4 | 35.5 |
Tetracycline | 76 | ≤2 to >16 | ≤2 | ≤2 | 92.1 |
Vancomycin | 76 | ≤0.25 to 2 | 0.50 | 1 | 100 |
Trimethoprim-sulfamethoxazole | 76 | ≤0.5 to >4 | >4 | >4 | 18.4 |
Tigecycline | 76 | ≤0.03 to >0.5 | 0.12 | 0.25 | ND |
Rifampin | 76 | ≤0.5 to >4 | ≤0.5 | ≤0.5 | 97.4 |
Quinupristin-dalfopristin | 76 | ≤0.5 to 4 | ≤0.5 | 2 | 89.5 |
Linezolid | 76 | ≤1 | ≤1 | ≤1 | 100 |
Gentamicin | 76 | ≤2 to >16 | ≤2 | >16 | 81.6 |
Daptomycin | 75 | ≤0.5 to >4 | ≤0.5 | 1 | 89.5 |
Chloramphenicol | 75 | ≤2 to >16 | 4 | 16 | ND |
Nitrofurantoin | 76 | ≤32 to >64 | >64 | >64 | ND |
- ↑ 1.0 1.1 Neemuchwala A, Soares D, Ravirajan V, Marchand-Austin A, Kus JV, Patel SN. In Vitro Antibiotic Susceptibility Pattern of Non-diphtheriae Corynebacterium Isolates in Ontario, Canada, from 2011 to 2016. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e01776-17. doi: 10.1128/AAC.01776-17. PMID: 29339389; PMCID: PMC5914010.